EK - Local recommendations (Respiratory)
Use documents past their review date with caution
Airways disease, obstructive
| Recommendation | Approval date | Review date |
| K&M Rescue Pack COPD | December 2023 | December 2025 |
| Primary Care Management of COPD | January 2025 | January 2027 |
| Interim Position Statement Carbon Footprint of Inhalers | February 2022 | February 2024 |
| Asthma inhaler guidelines (age 12-adult) | August 2023 | August 2025 |
| Asthma inhaler guidelines (Paediatric Under 12 years) | December 2023 | December 2025 |
| COPD Self-Management of Flare-ups Guide | February 2022 | February 2024 |
Allergic conditions
| Recommendation | Approval date | Review date |
| Allergic Rhinoconjunctivitis Treatment Pathway for Children (<16 years of age) | February 2025 | February 2027 |
| Allergic Rhinoconjunctivitis Treatment Pathway for ADULTS | April 2025 | April 2027 |
| Prescribing of Adrenaline Auto-Injectors | December 2021 | April 2023 |
General (Respiratory)
| Recommendation | Approval date | Review date |
| Inhaler Identification Aid EKPG | June 2019 | June 2022 |
| Contact details to obtain placebos for inhaler devices | June 2019 | June 2022 |
| PR2020-02 Omalizumab for CIndUs | February 2020 | February 2023 |
Inhaler technique guidance
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary